Fistel Vesicovaginalis, Ureterocutaneous, dan Ureterorectalis
Transcript of Fistel Vesicovaginalis, Ureterocutaneous, dan Ureterorectalis
-
7/23/2019 Fistel Vesicovaginalis, Ureterocutaneous, dan Ureterorectalis
1/24
BAGIAN ILMU BEDAH CASE REPORT
FAKULTAS KEDOKTERAN NOVEMBER 2013
UNIVERSITAS HASANUDDIN
Wanita dengan Fistel Vesicovaginalis, Ureterocutaneous,
dan Ureterorectalis
OLEH :
Julie C! G! U"#$%
C1110&20'
PEMBIMBING :
()! M! T*+*,i J$u-$)i
SUPERVISOR:
()! S.$/)i S.$-)i) S! U
BAGIAN ILMU BEDAH
FAKULTAS KEDOKTERAN
UNIVERSITAS HASANUDDIN
MAKASSAR
2013
-
7/23/2019 Fistel Vesicovaginalis, Ureterocutaneous, dan Ureterorectalis
2/24
HALAMAN PENGESAHAN
$+ #e)$+($$+$+ (i #$,$- i+i "e+.$$/$+ #$-,$:
N$"$ : Julie C! G! U"#$%
NIM : C111 0& 20'
Ju(ul4 : 5$+i$ (e+$+ Fi%el Ve%i6*7$i+$li% U)ee)*6u$+e*u% ($+
U)ee)*)e6$li%
Tel$- "e+.ele%$i/$+ u$% case report($l$" )$+/$ /e$+ie)$$+ /li+i/ $($
#$i$+ Il"u Be($- F$/ul$% Ke(*/e)$+ U+i7e)%i$% H$%$+u((i+!
M$/$%%$) N*7e"#e) 2013
Sue)7i%*) Pe"#i"#i+
()! S.$/i) S.$-)i) S! U ()! M! T*+*,i J$u-$)i
-
7/23/2019 Fistel Vesicovaginalis, Ureterocutaneous, dan Ureterorectalis
3/24
Laporan Kasus
Wanita dengan Fistel Vesicovaginalis, Ureterocutaneous, dan UreterorectalisJuliet C G Umbas, Tontowi Jauhari, Syakri Syahrir
Sub Bagian Bedah Urologi. Bagian Ilmu Bedah. akultas !edokteran Uni"ersitas #asanuddin
Summary
$eporting case, %emale && years old with "esico"aginalis,
ureterocutaneous, and ureterorectalis %istulae with e'tra"asation urine to genital
organs as the chie% complaint. (atient has been ha"ing this complaint %or )
month. *n anamnesis there are true incontinence symptom such as urine
e'tra"asation to the "agina without %eeling o% urinating and without reali+ing it,
persistantly, and do not change when the patient lying, sitting or standing. There
are also complaint where her %eces is mi'ed with urine when the patient de%ecate.#istory o% histerectomy two months ago, %ollowed by se"ere %lank pain on the le%t
side %or two days post operation and urine coming out %rom the unhealed
operation wound ) month later.
Urographine CTscan is done to conclude le%t hydronephrosis and le%t
hydroureter caused by total obstruction o% the le%t distal ureter. There are relation
between le%t ureter to the rectum and abdominal wall, and bladder to "agina.
-e%t nephrotomy is done to di"erse the urine temporarily and a%ter that
there is no "isible o% le%t ureter %istulae track with the rectum and abdominal
wound that pro"ed by (G e'amination, and healing o% abdominal wound.
RingkasanDil$*)/$+ /$%u% 8i%el 7e%i6*7$i+$li% u)ee)*6u$+e*u% ($+
u)ee)*)e6$li% $($ ,$+i$ u"u) 99 $-u+ (e+$+ /elu-$+ u$"$ /e+6i+
"e)e"#e% "el$lui li$+ /e"$lu$+ .$+ (i$l$"i %e$/ 1 #ul$+! P$($ $+$"+e%i%
(i($$/$+ e$l$ true incontinence #e)u$ u)i+e /elu$) "el$lui li$+ 7$i+$
$+$ )$+%$+$+ "i/%i ($+ $+$ (i%$($)i e)u% "e+e)u% #$i/ ,$/u #e)#$)i+
(u(u/ $$uu+ #e)(i)i! Te)($$ ul$ /elu-$+ i+$ #e)6$"u) u)i+e %$$ #u$+ $i)
#e%$)! Ri,$.$ "e+$l$+i *e)$%i e+$+/$$+ u"*) /$+(u+$+ 2 #ul$+ l$lu
.$+ (i%u%ul (e+$+ /elu-$+ +.e)i -e#$ $($ i+$+ /i)i %el$"$ 2 -$)i $%6$
*e)$%i ($+ lu/$ *e)$%i e)#u/$ (i%e)$i+.$ /elu$) u)i+e $($ lu/$ 1 #ul$+
/e"u(i$+!
Dil$/u/$+ e"e)i/%$$+ CT S6$+ u)*)$8i+ (e+$+ #u/i $($+.$
-i()*+e8)*%i% ($+ -i()*u)ee) /i)i $/i#$ *#%)u/%i *$l u)ee) /i)i #$i$+ (i%$l
$($+.$ -u#u+$+ u)ee) /i)i (e+$+ )e6u" ($+ (i+(i+ $#(*"e+ %e)$ 7e%i6$
u)i+$)i$ (e+$+ 7$i+$!
Dil$/u/$+ *e)$%i +e8)*%*"i /i)i (e+$+ uu$+ (i7e)%i %e"e+$)$ u)i+e
($+ ($+ "e"#e)i/$+ -$%il i($/ $"$/ l$i )e/ 8i%el u)ee) /i)i (e+$+ )e/u"
($+ (i+(i+ $#(*"e+ .$+ (i#u/i/$+ (e+$+ e"e)i/%$$+ APG %e)$ lu/$
$#(*"e+ .$+ "ul$i "e+e)i+!
-
7/23/2019 Fistel Vesicovaginalis, Ureterocutaneous, dan Ureterorectalis
4/24
Pendahuluan
Fi%el $($l$- /*"u+i/$%i $#+*)"$l $+$)$ (u$ eiel e)"u/$$+!1Fi%ul$
7e%i6*7$i+$li% "e)u$/$+ #e+u/ -u#u+$+ .$+ $li+ %e)i+ (ie"u/$+ $+$)$
)$/u% u)i+$)iu% e88e)e+ ($+ )$/u% e+i$li$!2
A+/$ /e$(i$+ e)#e+u/+.$ 8i%ul$ .$+ $/i#$ -i%e)e/*"i el$- (i
-iu+ $+$)$ 1 e) 1330 *e)$%i (i I+)i% UK! Dil$*)/$+ ul$ #$-,$ $+/$
/e$(i$+ e+.$/i i+i $/i#$ )$(i$%i u+u/ /e$+$%$+ i+e/*l*i $($l$- $+$)$
1; ($+ '; %e($+/$+ $/i#$ e/%e+e)$%i el7i/ "u+/i+ %e/i$) 10;!3Pe+elii$+
ei(e"i*l*i u$ "e+.$$/$+ #$-,$ /$%u%Fi%ul$ 7e%i6*7$i+$li% le#i- %e)i+
(ie"u/$+ $($ )i"i$)$ ?
P$($ 8i%el
7e%i6*6u$+e*u% e)$(i /e#*6*)$+ u)i+e %e6$)$ e)u% "e+e)u% .$+ "e+.e#$#/$+
e)$(i+.$ "$%e)$%i ($+ /e-$+6u)$+ ($)i /uli #e)%$"$$+ (e+$+ e)$(i+.$
i+8e/%i )$%$ i($/ +.$"$+ ($+ #$u i($/ %e($!&Ge$l$ ($+ $+($=$+($ 8i%ul$
u)ee)*e+e)i6$ $($l$- $($+.$ u)i+e (i 8e6e%!1
-
7/23/2019 Fistel Vesicovaginalis, Ureterocutaneous, dan Ureterorectalis
5/24
U+u/ "e+(i$+*%i% $($+.$ 8i%el (i#uu-/$+ $+$"+e%i% e"e)i/%$$+
8i%i% #e)u$ e% D.e!3 Di$"#$- l$i e"e)i/%$$+ e+u+$+ #e)u$ MSCT
$#(*"e+ (e+$+ /*+)$%!
Pe+*#$$+ (il$/u/$+ %e6$)$ e"#e($-$+! P$($ /$%u% /$"i i+i (il$/u/$+
+e8)*%*"i .$+ #e)uu$+ u+u/ (i7e)%i u)i+e %e"e+$)$! Di-$)$/$+ 8i%el
u)ee)*e+e)i6$ ($+ u)ee)*6u$+e*u% ($$ "e+uu (e+$+ %e+(i)i+.$! Se-i+$
/*"li/$%i $/i#$ 8i%el ($$ (i"i+i"$li%i) ($+ ($$ (i)e+6$+$/$+ *e)$%i $-$
%el$+u+.$!
Laporan Kasus
Se*)$+ ,$+i$ N.! J 99 $-u+ "$%u/ )u"$- %$/i 5$-i(i+
Su(i)*-u%*(* $($ $+$l 19 Au%u% 2013 (e+$+ /elu-$+ u$"$ /e+6i+
"e)e"#e% "el$lui lu#$+ /e"$lu$+ .$+ (i$l$"i %e$/ 1 #ul$+ .$+ l$lu (i"$+$
/e+6i+ /elu$) %e$+$+ -$)i $+$ (i%$($)i "e"#$%$-i $/$i$+ e+(e)i$
%e-i+$ e)$/%$ "e"$/$i **/! Kelu-$+ (i%e)$i i+$ #e)6$"u) /e+6i+ .$+
/elu$) "el$lui (u#u) (i$l$"i %e$/ 1 #ul$+ .$+ l$lu! Pe+(e)i$ u$ "e+elu-
%e)i+ #$%$- $($ lu/$ *e)$%i /$)e+$ /e+6i+ .$+ "e)e"#e%!
Ri,$.$ "e+$l$+i *e)$%i u"*) /$+(u+$+ (i RS! B*+e 2 #ul$+ .$+
l$lu! Seel$- *e)$%i e+(e)i$ "e+elu- +.e)i i+$+ -e#$ $($ i+$+ /i)i
(i$l$"i %e$/ 2 -$)i $%6$ *e)$%i (ii/ui (e+$+ e)#u/$+.$ lu/$ *e)$%i ($+
/elu$) u)i+e "el$lui lu/$ *e)$%i 1 #ul$+ $%6$ *e)$%i!
Pemeriksaan Fisis
Status Generalis : S$/i %e($+ ii 6u/u 6*"*%"e+i%
Status Vitalis :T : 120&0 ""H
N : &' /$li"e+i
-
7/23/2019 Fistel Vesicovaginalis, Ureterocutaneous, dan Ureterorectalis
6/24
P : 20 /$li"e+i
S : 3>?*C
Status Urologis
$egio costo"ertebra /01 et /S1nspeksi : $"$/ ,$)+$ /uli %$"$ (e+$+ %e/i$) alignment
7e)e#)$ #$i/ i##u% i($/ $($ i($/ $"$/ $+($=$+($ i+8l$"$%i
"$%%$ u"*) i($/ $($
Palpasi : N.e)i e/$+ i($/ $($ "$%%$ u"*) )i($/ $($
ballottementi+$l i($/ e)$#$
Perkusi : N.e)i /e*/ i($/ $($
$egio abdomen
nspeksi : $"$/ #e/$% lu/$ *e)$%i l$$)**"i (e+$+ lu/$*e)$%i e)#u/$ (i#$,$- u"#ili6u% %e$+$+ 3 6" $"$/ u% le$/$e
6$i)$+ i($/ $($ "$%%$ u"*) i($/ $($
Palpasi : $#(*"e+ %-*u8le "$%%$ u"*) i($/ $($ +.e)i e/$+
i($/ $($
Perkusi : i"$+i +.e)i /e*/ i($/ $($
$egio suprapubik
nspeksi : D$$) $"$/ %6$) #e/$% lu/$ *e)$%i el$- "e+e)i+
i($/ $($ "$%%$ u"*) i($/ $"$/ 8i%el i($/ $"$/ $+($=$+($
i+8l$"$%i i($/ $"$/ #uli+ #uli=#uli
Palpasi : +.e)i e/$+ i($/ $($ i($/ e)$#$ #uli=#uli i($/ e)$#$
"$%%$ u"*)
$egio genitalia e'terna
Vulva
nspeksi : $"$/ l$#i$ "$.*) ,$)+$ /uli %$"$ (e+$+ %e/i$)+.$
i($/ $"$/ "$%%$ u"*) $"$/ l$#i$ "i+*) ,$)+$ le#i- el$ ($)i
%e/i$)+.$ i($/ $"$/ "$%%$ u"*) e)$%$+ F*le. 6$-ee) 1> $($
OUE i($/ $"$/ "$%%$ u"*) $"$/ /elu$) u)i+e le,$ lu#$+
7$i+$ i($/ $($ ($)$-
Palpasi : N.e)i e/$+ i($/ $($ "$%%$u"*) i($/ $($
Perineum
-
7/23/2019 Fistel Vesicovaginalis, Ureterocutaneous, dan Ureterorectalis
7/24
nspeksi : $"$/ ,$)+$ /uli le#i- el$ ($)i %e/i$)+.$ i($/
$"$/ "$%%$ u"*) i($/ $"$/ 8i%el "$uu+ $+($=$+($ i+8l$"$%i
Palpasi : N.e)i e/$+ i($/ $($ "$%%$ u"*) i($/ e)$#$
Vaginal !oucher"
= e)$#$ "u/*%$ 7$i+$ li6i+ i($/ e)$#$ "$%%$ u"*)
= e)$#$ 8*)+i +.e)i e/$+
-
7/23/2019 Fistel Vesicovaginalis, Ureterocutaneous, dan Ureterorectalis
8/24
5$)+$ Ku+i+ /e)u- Blood 190
H & Leu/*%i 900
BJ 1!010 Vi! C =
P)*ei+ Ne$i8 Se(i"e+ leu/*%i 30
Glu/*%$ Ne$i8 Se(i"e+ e)i)*%i '0
Bili)u#i+ Ne$i8 Se(i"e+ *)$/ =
U)*#ili+*e+ N*)"$l Se(i"e+ /)i%$l =
Ke*+ Ne$i8 Se(i"e+ eiel %el 10
Ni)i P*%ii8 Se(i"e+ l$i+=l$i+ =
-
7/23/2019 Fistel Vesicovaginalis, Ureterocutaneous, dan Ureterorectalis
9/24
Pemeriksaan Penun-ang Lainnya
= MSCT $#(*"e+ 2?==2013 :
-
7/23/2019 Fistel Vesicovaginalis, Ureterocutaneous, dan Ureterorectalis
10/24
-
7/23/2019 Fistel Vesicovaginalis, Ureterocutaneous, dan Ureterorectalis
11/24
H$%il e"e)i/%$$+ MSCT $#(*"e+ (e+$+ /*+)$% **+$+ $i$l
)e8*)"$ %$i$l ($+ 6*)*+$l (e+$+ -$%il %e#$$i #e)i/u :
= T$"$/ /*+)$% "e+i%i /e(u$ PCS u)ee) ($+ #uli #uli (e+$+
(il$$%i $($ PCS ($+ u)ee) /i)i! Di+(i+ #uli=#uli i)eule) e)u$"$
$($ %i%i /i)i (i%e)$i $"#$)$+ $i) 8lui( le7el (i($l$"+.$! T$"$/
e/%)$7$%$%i /*+)$% ($)i u)ee) /i)i /e )e6u" ($+ #uli=#uli /e 7$i+$
"el$lui (i+(i+ l$e)**%e)i*) #uli=#uli! T$"$/ ul$ e/%)$7$%$%i
/*+)$% /e )*+$ e)i*+eu"!
= Gi+$l /$+$+ : u/u)$+ ($+ (e+%i$% ($l$" #$$% +*)"$l! Ti($/ $"$/
(il$$%i PCS! Ti($/ $"$/ (e+%i$% #$uSOL!
= Gi+$l /i)i : u/u)$+ ($l$" #$$% +*)"$ $"$/ (il$$%i PCS! Ti($/
$"$/ (e+%i$% #$uSOL!= U)ee) /$+$+ +*)"$l u)ee) /i)i $"$/ (il$$%i ($+ /i+/i+ $($
13 )*/%i"$l!
= L**=l** u%u% .$+ e)%6$+ ($l$" #$$% +*)"$l!
= T$"$/ *%e*8i $($ CV lu"#$li%
-
7/23/2019 Fistel Vesicovaginalis, Ureterocutaneous, dan Ureterorectalis
12/24
!indakan Pem#edahan )/'%(')(%*
= Dil$/u/$+ *e+ +e8)*%*"i u+u/ (i7e)%i u)i+e $)%i$l %e"e+$)$
= L$*)$+ Oe)$%i:
o P$%ie+ (i#$)i+/$+ ($l$" *%i%i l$e)$l (e6u#iu% /i)i (i #$,$- e+$)u-
$+e%e%i
o Di%i+8e/%i ($+ ()$i+
o I+%i%i (i$*+$l ($)i i 6*%$ II /e $)$- u"#ili/u% %e$+$+ & 6"
e)($l$" %e6$)$ $$" %$"$i e"#u% )*+$ )e)*e)i*+e$l
o Si%i-/$+ e)i*+eu" /e $)$- "e(i$l %$"$i m. psoas e)$$) (e+$+
el$% #u/$ 8$%6i$ e)*$
o I(e+i8i/$%i u)ee) #e#$%/$+ ($)i $)i+$+ %e/i$) euel
o Su%u)i u)ee) %$"$i /e .elu" i+$l (e+$+ "e"#e#$%/$+ ($)i
$)i+$+ %e/i$)
o Be#$%/$+ i+$l ($)i le"$/ e)i)e+$l (i#u$ i+%i%i %e$+$+ 16" $($
border line pool#$,$- i+$l e)($l$" %e6$)$ u"ul %$"$i e"#u% /e
.elu"
o M$%u//$+ 8*le. 6$-ee) 1>F /e ($l$" i+$l /e ($l$" i+$l ($+ 8i/%$%i
#$l*+ /$ee) 9 66 (il$+u/$+ (e+$+ 8i/%$%i /e (i+(i+ $#(*"e+
o Cu6i )*+$ )e)*e)i*+e$l /*+)*l e)($)$-$+
o J$-i lu/$ *e)$%i l$i% (e"i l$i%
o Oe)$%i %ele%$i (e+$+ 1 #u$- ()$i+!
Pera0atan Pasca 1edah
= Be)$l$+ (e+$+ #$i/ $+$ e+.uli$+
= R$,$ lu/$ ($+ ()$i+
= K*+)*l )$(i*l*i #e)u$ 8** APG >=11=2013
-
7/23/2019 Fistel Vesicovaginalis, Ureterocutaneous, dan Ureterorectalis
13/24
-
7/23/2019 Fistel Vesicovaginalis, Ureterocutaneous, dan Ureterorectalis
14/24
H$%il e"e)i/%$$+ APG (e+$+ -$%il %e#$$i #e)i/u :
2PG "
= K*+)$% %e#$+.$/ 120 66 (i"$%u//$+ "el$lui /$ee) .$+
e)$%$+ $($ (i+(i+ $#(*"e+ %e#el$- /i)i
= T$"$/ /*+)$% "e+i%i 6$l.6e% el7i% )e+$li% ($+ u)ee) /i)i
= T$"$/ /*+)$% e)$-$+ $($ (i%$l u)ee) /i)i (e+$+ (il$$%i
u)ee) ($+ /i+/i+ 13 )*/%i"$l+.$
Ke%$+ : O#%)u/%i (i%$l u)ee) /i)i =11=2013 e+(e)i$ ul$+ (e+$+ ()$i+ "$%i- e)$%$+
= K*+)*l (i *li/li+i/
.iskusi
Fi%ul$ $($l$- /*"u+i/$%i $#+*)"$l $+$)$ (u$ eiel e)"u/$$+! Fi%ul$
Ve%i6*7$i+$l
-
7/23/2019 Fistel Vesicovaginalis, Ureterocutaneous, dan Ureterorectalis
15/24
u$ (ie"u/$+ le#i- i+i $($ ,$+i$ (e+$+ i+i #$($+ /u)$+ ($)i 190 6"
u%i$ /u)$+ ($)i 29 $-u+ 9;@ ,$+i$ #e)e+(i(i/$+ )e+($-
-
7/23/2019 Fistel Vesicovaginalis, Ureterocutaneous, dan Ureterorectalis
16/24
($)i /e(u$ %i%e"!11 P$%ie+ /$"i (i(u$ "e+$l$"i 8i%el u)ee)*6u$+e*u% ($+
8i%el u)ee)*)e6$li% (i(u$ /$)e+$ $($+.$ 6e(e)$ u)ee) $($ %$$ *e)$%i! P$($
li$%i u)ee) .$+ i($/ e)(ee/%i %e#$i$+ (i+(i+ u)ee) "e+$l$"i +e/)*%i%
/$)e+$ e/$+$+ .$+ (i%e#$#/$+ *le- i%/e"i$! Se"e+ u)ee) .$+ i%/e"i/
$/-i)+.$ $/$+ "ele"$- %e-i+$ ($$ e)$(i u)i+*"$ .$+ #e%$) %e-i+$
e)$(i e/%)$7$%$%i u)i+e /e ($l$" $)i+$+ e)iu)ee)$l .$+ /e"u(i$+ $/$+
"e+.e#$#/$+ e"#e+u/$+ 8i%el!12 13
Ke#*6*)$+ u)i+e .$+ i($/ e)/*+)*l
-
7/23/2019 Fistel Vesicovaginalis, Ureterocutaneous, dan Ureterorectalis
17/24
e)$(i /$)e+$ (i(u$ $($ -u#u+$+ l$+%u+ $+$)$ u)ee) ($+ )e6u" #e)u$
8i%el u)ee)*)e6$li%!
Hi()*+e8)*%i% .$+ (i$l$"i *le- $%ie+ /$"i (i(u$ e)$(i /$)e+$
"e)u$/$+ /*"li/$%i ($)i 6e(e)$ u)ee)! Ji/$ li$%i *$l $($ u)ee) e)$(i u)i+e
.$+ #e)$%$l ($)i i+$l i%il$e)$l e)-$"#$ "e+$li) /e 7e%i6$ u)i+$)i$ .$+
($$ "e+.e#$#/$+ e)$(i+.$ -i()*+e8)*%i% ($+ /e)u%$/$+ 8u+%i i+$l
i%il$e)$l .$+ )*)e%i8!12 E/%)$7$%$%i u)i+e /)*+i/ .$+ e)$(i /$)e+$ )$u"$
.$+ i($/ e)(ee/%i ($$ "e+.e#$#/$+ e"#e+u/$+ u)i+*"$ .$+ #e%$) (i
)e)*e)i*+e$l! Hi()*+e8)*%i% $/u $/i#$ li$%i u)ee) *$l "e+.e#$#/$+ +.e)i
i+$+ -e#$ $($ %$$ $,$l $%6$ *e)$%i!13
U+u/ "e+(i$+*%i% $($+.$ 8i%el (i#uu-/$+ $+$"+e%i% e"e)i/%$$+
8i%i% ($+ e"e)i/%$$+ e+u+$+! Be)($%$)/$+ $+$"+e%i% (i($$/$+ e$l$ /li+i%
.$+ %e%u$i (e+$+ .$+ el$- (iel$%/$+ (i $$%! Pe"e)i/%$$+ 7$i+$ .$+ elii
"e+u+$/$+ %e/ulu" ($$ "e"#e)i/$+ $"#$)$+ 7i%u$l %$lu)$+ 8i%ul$!
Ku$li$% ($+ /u$+i$% $)i+$+ 7$i+$ ($+ %e/i$)+.$ -$)u% (i+il$i! Ke#$+.$/$+
8i%ul$ .$+ #e)/e"#$+ %eel$- i+($/$+ -i%e)e/*"i #i$%$++.$ #e)$($ (i
li+/$) 7$i+$! U+u/ %$lu)$+ 8i%ul*u% .$+ i($/ "u($- (ili-$ 7e%i6$ u)i+$)i$
#i%$ (ii%i (e+$+ Meile+ Bi)u .$+ (ie+6e)/$+ ($+ /e#*6*)$+ 6$i)$+ #i)u e)%e#u
($$ (i+il$i (i 7$i+$! P$($ $%ie+ i+i el$- (il$/u/$+ e% D.e (e+$+
"e+u+$/$+ l$)u$+ "e-.le+ #lue ($+ (ie"u/$+ $($+.$ l$)u$+ "e-.le+ #lue
.$+ /elu$) "el$lui lu/$ #e/$% *e)$%i ($+ $+u%! P.el*)$-. Re)*)$(e -$)u%
(il$/u/$+ $($ $%ie+ .$+ (i6u)i$i "/e"ili/i 8i%ul$ u)ee)*7$i+$l! Ji/$
(i$+*%i% 8i%ul$ 7e%i6*7$i+$li% "$%i- %uli (ie$//$+ 6$i)$+ .$+ "e+$li) ($)i
7$i+$ -$)u% ($$ (i#u/i/$+ %e#$$i u)i+e! Di$+*%i% ($$ (i/*+8i)"$%i i/$
-
7/23/2019 Fistel Vesicovaginalis, Ureterocutaneous, dan Ureterorectalis
18/24
u"l$- 6$i)$+ .$+ (i/u"ul/$+ 6u/u u+u/ $+$li%i% /)e$i+i+! Nil$i /)e$i+i+
.$+ (ie"u/$+ -$)u% (u$ /$li le#i- #$+.$/ ($)i u"l$- /)e$i+i+ %e)u"! Ji/$
e+u/u)$+ /)e$i+i+ %$"$ (e+$+ $$u /u)$+ ($)i +il$i /)e$i+i+ %e)u" "$/$
6$i)$+ e)%e#u -$)u% (i(u$ #e)$%$l ($)i %u"#e) l$i+ %ee)i 6$i)$+ e)i*+e$l
6$i)$+ li"8$i/ %e/)e%i u#$ 8$ll*i $$u 6$i)$+ 7$i+$!1
Te% (i$+*%i% e)"$%u/ e% "eile+ #i)u (i"$+$ 1 "l 6$i)$+ e/$ "eile+
#i)u (il$)u/$+ ($l$" 100 "l +$6l 0; /e"u(i$+ (i"$%u//$+ /e($l$" 7e%i6*
u)i+$)i$ 7i$ /$ee) ($+ "$%u//$+ $"*+ /e ($l$" 7$i+$! i/$ $"*+ "e+$(i
#e),$)+$ #i)u "$/$ ($$ (ii+(i/$%i/$+ $($+.$ 8i%ul$ 7e%i6*7$i+$li%! i/$
$"*+ .$+ (i"$%u//$+ i($/ #e),$)+$ "$/$ e"#e)i$+ indigo carmine
-
7/23/2019 Fistel Vesicovaginalis, Ureterocutaneous, dan Ureterorectalis
19/24
Ti+($/$+ e"e)i/%$$+ l$i+ .$+ u$ e)lu (il$/u/$+ $($ %e"u$ $%ie+
.$+ %e6$)$ *#e/i8 "e+$"$//$+ $($+.$ 8i%ul$ $$u $($ e+il$i$+ u+u/ #u/i
$$u+ .$+ "e+$)$- /e$($ )*l$% "$uu+ i+/*+i+e+%i$ u)i+e ie %)e%%
$($l$- "oiding cystourethrogram
-
7/23/2019 Fistel Vesicovaginalis, Ureterocutaneous, dan Ureterorectalis
20/24
Se($+/$+ e+(e/$$+ 7i$ $#(*"e+ le#i- #e)i%i/* #$i $%ie+ $/$+ e$i
(ie)lu/$+ u+u/ e)#$i/$+ 8i%ul$ .$+ #e)u/u)$+ le#i- ($)i 2 6" $$u 8i%el
.$+ i"#ul $%6$ )$(i$%i $$u %eel$- e)#$i/$+ %e#elu"+.$ $$l $$u i/$
e)($$ i+(i/$%i u+u/ *e)$%i $#(*"e+ l$i++.$
-
7/23/2019 Fistel Vesicovaginalis, Ureterocutaneous, dan Ureterorectalis
21/24
(il$/u/$+ e/%l*)$%i ($+ e)#$i/$+ le#i- l$+u! D)$i+$%e +e8)*%*"i e)/u$+eu%
)$/u% u)i+$)iu% )*/%i"$l $$u +e8)*%*"i #i%$ (ie)i"#$+/$+ i/$ 6e(e)$
e)l$"#$ (i/e+$li $$u i/$ $%ie+ "e"ili/i /*"li/$%i .$+ %i+i8i/$+ .$+
"e"#u$ )e/*+%)u/%i i($/ "e"u$%/$+! Tuu$+ ($)i e)#$i/$+ u)ee) $($l$-
u+u/ "e"e)*le- (e#)i(e"e+ %e"u)+$ #e#$% ($)i $+$%*"*%i% watertight
closure %e+i+ u)ee)
-
7/23/2019 Fistel Vesicovaginalis, Ureterocutaneous, dan Ureterorectalis
22/24
G$"#$) '! B*$)i%lap19
P)*+*%i% 8i%ul$ 7e%i6*7$i+$li% .$+ e)$(i $/i#$ e)lu/$$+ %$$ *e)$%i
($$ (i e)#$i/i (e+$+ %u/%e% $($ %e/i$) ?9=?; /$%u%! A+/$ /e$$l$+
%e#e%$) 10; el$- (il$*)/$+ $($ e)#$i/$+ 8i%ul$ )e/u)e+! Fi%ul$ )e/u)e+
($$ e)$(i ($l$" 3 #ul$+ %eel$- e)#$i/$+ 8i%ul$ )i"e)! P)*+*%i% u+u/ 8i%el
)$/u% u)i+$)iu% #$i/ i/$ (i(i$+*%i% %e(i+i "u+/i+ ($+ (ii+($/i %e6$)$ e$!
Di$+*%i% .$+ l$"#$ "e"e)#u)u/ (i$+*%i% /$)e+$ ($$ e)$(i i+8e/%i
-i()*+e8)*%i% $#%e% ($+ e"#e+u/$+ 8i%ul$!13
-
7/23/2019 Fistel Vesicovaginalis, Ureterocutaneous, dan Ureterorectalis
23/24
.a3tar Ru-ukan
1! M$)+e JA C$%ell$+*% VH e $l! Di$+*%i% $+( "$+$e"e+ *8
7e%i6*7$i+$l 8i%ul$%: ,e+. .e$)% *8 ee)ie+6e! Re7 Me U)*l!2011! V*l!
?1! M$+%/i D! Ve%i6*7$i+$l 8i%ul$! %e)i$l *+li+e! 2013! 6ie( *+ 10-
N*7e"#e) 2013! A7$il$#le 8)*": -:,,,!u)*l*.=
e#**/!6*"7e%i6*7$i+$l=8i%ul$!-"l
?! Su)l*6/ J C-el"*, D! Ve%i6*7$i+$l Fi%ul$%e)i$l *+li+e! 2012! 6ie( *+
10- N*7e"#e) 2013! A7$il$#le 8)*":
-:e"e(i6i+e!"e(%6$e!6*"$)i6le2>?'3=*7e)7ie,%-*,$ll
&! T*u8iue H! Me)$+i A! J! Ve%i6*6u$+e*u% 8i%ul$! 2011! J P$/ Me( A%%*6!
V*l! >1 N*! !
! Bu)i7*+ e! $l! C*""*+ L*,e) U)i+$). T)$6 Fi%ul$%: A )e7ie, *8 Cli+i6$l
P)e%e+$i*+% C$u%e% $+( R$(i*)$-i6 I"$i+! IJCRI! 2011! V*l 2
-
7/23/2019 Fistel Vesicovaginalis, Ureterocutaneous, dan Ureterorectalis
24/24
12! V$%$7$($ S! P! MD! U)ee)e$l I+u). Du)i+ G.+e6*l*i6 Su)e).! 2013!
6ie( *+ 2>- N*7e"#e) 2013! A7$il$#le 8)*":
-:e"e(i6i+e!"e(%6$e!6*"$)i6le'9'>1?13! T$+$-* E!A! M6A+i+6- J!5! S"i-% Ge+e)$l U)*l*.! 1?- E(! USA:
M6G)$, Hill! 200&! ! 2&?=!
1'! S$+u66i Ri6-$)( A! MD! U)ee)$l T)$u"$ T)e$"e+ M$+$e"e+! 2012!
6ie( *+ 2>- N*7e"#e) 2013! A7$il$#le 8)*":
-:e"e(i6i+e!"e(%6$e!6*"$)i6le''033=)e$"e+
19! Ell%,*)- P$"el$ I MD! U)ee)*+e*6.%*%*".! 2012! 6ie( *+ 2>-
N*7e"#e) 2013! A7$il$#le 8)*":
-:e"e(i6i+e!"e(%6$e!6*"$)i6le1&30'=*7e)7ie,$1
http://emedicine.medscape.com/article/440933-treatmenthttp://emedicine.medscape.com/article/1893904-overview#a1http://emedicine.medscape.com/article/440933-treatmenthttp://emedicine.medscape.com/article/1893904-overview#a1